Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Bioanalysis
|
October 17, 2019
Current challenges in assessing immunogenicity
Gopi Shankar
Trends in Biotechnology
|
November 22, 2002
Immune monitoring: it's prudent to adopt current quality regulations
Gopi Shankar
Bioanalysis
|
April 2, 2011
Bioanalytical interferences in immunoassays for antibody biotherapeutics
Charles Pendley, Gopi Shankar
Expert Opinion on Biological Therapy
|
April 17, 2002
Immune monitoring of cancer biotherapy: need for harmonising biotechnical prowess, practicality, and quality control
Gopi Shankar, Patricia A Lodge
Journal of Immunological Methods
|
February 26, 2004
The COSTIM bioassay: a novel potency test for dendritic cells
Gopi Shankar, Robert Bader, Patricia A Lodge
Nature Biotechnology
|
May 8, 2007
A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs
Gopi Shankar, Charles Pendley, Kathryn E Stein
Journal of Pharmaceutical and Biomedical Analysis
|
September 28, 2010
Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet(®) biolayer interferometry
Jian Li, Allen Schantz, Maureen Schwegler, et al.
Journal of Translational Medicine
|
October 29, 2003
Interferon-gamma Added During Bacillus Calmette-Guerin Induced Dendritic Cell Maturation Stimulates Potent Th1 Immune Responses
Gopi Shankar, Linda A Pestano, Marnix L Bosch
Bioanalysis
|
March 22, 2018
Application of automated liquid handling in ligand-binding assay-based bioanalytical method development: the practical considerations
Mark Ware, Gopi Shankar, Patrick Breslin, et al.
Trends in Biotechnology
|
April 25, 2006
Scientific and regulatory considerations on the immunogenicity of biologics
Gopi Shankar, Elizabeth Shores, Carrie Wagner, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Bioanalysis
|
October 17, 2019
Current challenges in assessing immunogenicity
Gopi Shankar
Trends in Biotechnology
|
November 22, 2002
Immune monitoring: it's prudent to adopt current quality regulations
Gopi Shankar
Bioanalysis
|
April 2, 2011
Bioanalytical interferences in immunoassays for antibody biotherapeutics
Charles Pendley, Gopi Shankar
Expert Opinion on Biological Therapy
|
April 17, 2002
Immune monitoring of cancer biotherapy: need for harmonising biotechnical prowess, practicality, and quality control
Gopi Shankar, Patricia A Lodge
Journal of Immunological Methods
|
February 26, 2004
The COSTIM bioassay: a novel potency test for dendritic cells
Gopi Shankar, Robert Bader, Patricia A Lodge
Nature Biotechnology
|
May 8, 2007
A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs
Gopi Shankar, Charles Pendley, Kathryn E Stein
Journal of Pharmaceutical and Biomedical Analysis
|
September 28, 2010
Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet(®) biolayer interferometry
Jian Li, Allen Schantz, Maureen Schwegler, et al.
Journal of Translational Medicine
|
October 29, 2003
Interferon-gamma Added During Bacillus Calmette-Guerin Induced Dendritic Cell Maturation Stimulates Potent Th1 Immune Responses
Gopi Shankar, Linda A Pestano, Marnix L Bosch
Bioanalysis
|
March 22, 2018
Application of automated liquid handling in ligand-binding assay-based bioanalytical method development: the practical considerations
Mark Ware, Gopi Shankar, Patrick Breslin, et al.
Trends in Biotechnology
|
April 25, 2006
Scientific and regulatory considerations on the immunogenicity of biologics
Gopi Shankar, Elizabeth Shores, Carrie Wagner, et al.
Page
of 4